Product Information
CITALOPRAM HBR 20 MG TABLET is a generic product labeled by Exelan Pharmaceuticals Inc., priced at $0.0290 per EA under NDC 76282062990. Its NADAC has been published 236 times since Feb 16, 2022.
FDA first approved this application on Oct 3, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Exelan Pharmaceuticals Inc.NDC
76282062990
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CITALOPRAM HYDROBROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077534FDA Approved
10/3/2006
TE Code
AB
On Market Since
11/10/2017
Pharmacological Classes
Price Statistics
The NADAC for CITALOPRAM HBR 20 MG TABLET has been published 236 times since Feb 16, 2022, and over the history we have for it it has risen 2.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0290 per EA |
|---|---|
| All-time high | $0.0328 (Feb 14, 2024) |
| All-time low | $0.0244 (Nov 20, 2024) |
| 52-week high | $0.0309 |
| 52-week low | $0.0284 |
| Median price | $0.0303 |
| Average price | $0.0302 |
| Largest weekly change | +23.4% (Aug 21, 2024) |
| Weeks tracked | 236 |
| Tracking since | Feb 16, 2022 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CITALOPRAM HBR 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CITALOPRAM HBR 20 MG TABLET, manufactured by Exelan Pharmaceuticals Inc., is $0.0290 per EA (NDC 76282062990), effective Aug 19, 2026.
How has the price of CITALOPRAM HBR 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for CITALOPRAM HBR 20 MG TABLET has risen 2.5%. It has been tracked across 236 weekly CMS publications since Feb 16, 2022.
What are the highest and lowest recorded NADAC prices for CITALOPRAM HBR 20 MG TABLET?
Since Feb 16, 2022, the NADAC for CITALOPRAM HBR 20 MG TABLET has ranged from a low of $0.0244 (Nov 20, 2024) to a high of $0.0328 (Feb 14, 2024), with a median of $0.0303 per EA.
Are there cheaper alternatives to CITALOPRAM HBR 20 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CITALOPRAM HBR 20 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CITALOPRAM HBR 20 MG TABLET?
CITALOPRAM HBR 20 MG TABLET (NDC 76282062990) is labeled by Exelan Pharmaceuticals Inc., and CMS classifies it as a generic product.